Longitudinal validation of the PROMIS-16 in a sample of adults in the United States with back pain

By sjmartinez • November 7, 2024

Rodriguez A, Zeng C, Hays RD, Herman PM, Edelen MO. Longitudinal validation of the PROMIS-16 in a sample of adults in the United States with back pain. Qual Life Res. 2024 Nov 6. doi: 10.1007/s11136-024-03826-6. Epub ahead of print. PMID: 39505759.

Tags: General Internal Medicine, health-related quality of life, patient-reported outcomes, PROMIS-16, PROMIS-29 + 2, Publications, Short form validation

Angiotensin Receptor-Neprilysin Inhibitor Prescribing Patterns in Patients Hospitalized for Heart Failure

Srivastava PK, Klomhaus AM, Greene SJ, Heidenreich P, Lewsey SC, Yancy CW, Fonarow GC. Angiotensin Receptor-Neprilysin Inhibitor Prescribing Patterns in Patients Hospitalized for Heart Failure.[...]

Agent-Based Model of Combined Community- and Jail-Based Take-Home Naloxone Distribution

Tatara E, Ozik J, Pollack HA, Schneider JA, Friedman SR, Harawa NT, Boodram B, Salisbury-Afshar E, Hotton A, Ouellet L, Mackesy-Amiti ME, Collier N, Macal[...]

Chlorthalidone vs Hydrochlorothiazide and Kidney Outcomes in Patients With Hypertension: A Secondary Analysis of a Randomized Clinical Trial

Ishani A, Hau C, Raju S, Wise JK, Glassman PA, Taylor AA, Ferguson RE, Cushman WC, Leatherman SM. Chlorthalidone vs Hydrochlorothiazide and Kidney Outcomes in[...]